Pfizer Inc logo

Pfizer Inc

€ 47.92 (-0.17%) Dec 6
P/E:
9.56
P/B:
3.01
Market Cap:
€ 265.83B ($ 279.37B)
Enterprise V:
€ 265.40B ($ 278.93B)
Volume:
582.00
Avg Vol (2M):
2.97K
Also Trade In:
Volume:
582.00
Market Cap €:
265.83B
Market Cap $:
279.37B
PE Ratio:
9.56
Avg Vol (2-Month):
2.97K
Enterprise Value €:
265.40B
Enterprise Value $:
278.93B
PB Ratio:
3.01

Business Description

Description
Pfizer is one of the world's largest pharmaceutical firms, with annual sales close to $50 billion (excluding COVID-19 product sales). While it historically sold many types of healthcare products and chemicals, now, prescription drugs and vaccines account for the majority of sales. Top sellers include pneumococcal vaccine Prevnar 13, cancer drug Ibrance, cardiovascular treatment Eliquis, and immunology drug Xeljanz. Pfizer sells these products globally, with international sales representing close to 50% of its total sales. Within international sales, emerging markets are a major contributor.